Literature DB >> 12694137

Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers.

J Albert1, A Radomski, A Soop, A Sollevi, C Frostell, M W Radomski.   

Abstract

BACKGROUND: Roughly 400.000 cases of sepsis occur every year in the United States only and this is associated with a very high mortality. Bacterial lipopolysaccharide (LPS) triggers systemic inflammatory reactions in sepsis. However, down-stream cellular cascade initiated by LPS is still being elucidated. Nitric oxide (NO) and matrix metalloproteinases-2 and -9 (MMP-2 and MMP-9) are known to be induced by LPS. We have investigated the release of NO, MMP-2 and MMP-9 following infusion of LPS to volunteers.
METHODS: IPS (2 ng kg-1) was infused to 10 healthy volunteers. Before the experiments were started the subjects had an intravenous catheters placed. An electrocardiogram was also placed and monitored constantly. Body temperature was measured by ear thermometer every 10 min Venous blood was collected and cell-free plasma assayed for the presence of MMP-2 and MMP-9 using zymography and NO using HPLC assay for NO metabolites, nitrite and nitrate.
RESULTS: The administration of LPS resulted in increased body temperature and tachycardia. Time-dependent release of MMP-9(30 fold increase from the baseline) peaking at 2 h following infusion of LPS was observed. LPS did not significantly modify the activity of MMP-2 (P > 0.05). Infusion of LPS did not significantly change the levels of nitrite and nitrate (from 60 +/- 11 to 67 +/- 10 micro m, P > 0.05).
CONCLUSION: The release of MMP-9, but not MMP-2 or NO, is a sensitive index of endotoxaemia in humans. MMP-9 release may contribute to the pathogenesis of sepsis via its pro-inflammatory effects on the vasculature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694137     DOI: 10.1034/j.1399-6576.2003.00059.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  16 in total

1.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

2.  Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases.

Authors:  Ada W Y Chung; Anna Radomski; David Alonso-Escolano; Paul Jurasz; Michael W Stewart; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2004-11-08       Impact factor: 8.739

3.  Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis.

Authors:  Subir R Maitra; Asha Jacob; Mian Zhou; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2010-06-16

4.  The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction.

Authors:  Eric D Adler; Vincent C Chen; Anne Bystrup; Aaron D Kaplan; Steven Giovannone; Karen Briley-Saebo; Wilson Young; Steve Kattman; Venkatesh Mani; Michael Laflamme; Wei-Zhong Zhu; Zahi Fayad; Gordon Keller
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

5.  Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.

Authors:  Felipe Dal-Pizzol; Hugo Alberto Rojas; Emilia Marcelina dos Santos; Francieli Vuolo; Larissa Constantino; Gustavo Feier; Matheus Pasquali; Clarissa M Comim; Fabrícia Petronilho; Daniel Pens Gelain; João Quevedo; José Cláudio Fonseca Moreira; Cristiane Ritter
Journal:  Mol Neurobiol       Date:  2013-03-12       Impact factor: 5.590

Review 6.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 7.  Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Authors:  Ineke Vanlaere; Claude Libert
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

8.  Detecting early kidney damage in horses with colic by measuring matrix metalloproteinase -9 and -2, other enzymes, urinary glucose and total proteins.

Authors:  Bela M Arosalo; Marja Raekallio; Minna Rajamäki; Elina Holopainen; Tuulia Kastevaara; Hanna Salonen; Satu Sankari
Journal:  Acta Vet Scand       Date:  2007-01-23       Impact factor: 1.695

9.  Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Authors:  Leonardo Lorente; María M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José A Rodríguez; Alejandro Jiménez; Juan M Borreguero-León; Felipe Belmonte; Juan C Medina; Maria C Llimiñana; José M Ferrer-Agüero; José Ferreres; María L Mora; Santiago Lubillo; Manuel Sánchez; Ysamar Barrios; Antonio Sierra; José A Páramo
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

10.  Increase in net activity of serine proteinases but not gelatinases after local endotoxin exposure in the peripheral airways of healthy subjects.

Authors:  Margaretha E Smith; Steven Bozinovski; Carina Malmhäll; Margareta Sjöstrand; Pernilla Glader; Per Venge; Pieter S Hiemstra; Gary P Anderson; Anders Lindén; Ingemar Qvarfordt
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.